Descrizione Progetto

CLINICAL SCIENCE JOURNAL CLUB OF EUSTAR YIG October 2019

This second edition of the clinical science journal club of the EUSTAR Young Investigators (YIG) summarizes some of the recent advances in Systemic Sclerosis related Interstitial Lung Disease (SSc-ILD). ILD is a relatively frequent complication in SSc, representing one of the main causes of morbidity and mortality. Current treatments for ILD include Cyclophosphamide and more recently Mycophenolate Mofetil (MMF). New therapeutic options are now on the horizon, mainly in the category of biologic drugs or small molecules.
READ MORE